{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:33:31Z","timestamp":1790638411380,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901146"],"award-info":[{"award-number":["81901146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771101"],"award-info":[{"award-number":["81771101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Huizhiyucai Project of the Third Xiangya Hospital, Central South University","award":["2020"],"award-info":[{"award-number":["2020"]}]},{"name":"the Key Laboratory of Hunan Province Grants","award":["2018TP1009"],"award-info":[{"award-number":["2018TP1009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>(1) Background: Chronic kidney disease (CKD) increases the susceptibility to the presence of herpes zoster (HZ). Little is known about the risk factors of HZ in CKD patients; (2) Methods: This is a case-control study. CKD patients diagnosed with HZ between January 2015 and June 2021 in a tertiary hospital were identified. One age- and gender- matched control was paired for each case, matched to the date of initial HZ diagnosis. Conditional multiple logistic regression was used to evaluate the risk factors associated with the presence of HZ; (3) Results: Forty-seven HZ patients and controls were identified. In general, about 73.40% (69 out of 94) patients were classified at IV to V stages of CKD. Immunosuppressive agents (p = 0.0012) and dialysis therapy (p = 0.021) were reported more frequently in the HZ cohort. Compared with the control group, the total white cell count and lymphocyte count were significantly lower in the HZ group (p value of 0.032 and 0.003, respectively). The conditional logistics regression model revealed that previous immunosuppressants administration (odds ratio: 10.861, 95% CI: 2.092~56.392, p = 0.005) and dialysis therapy (odds ratio: 3.293, 95% CI: 1.047~10.355, p = 0.041) were independent risk factors of HZ in the CKD population; (4) Conclusions: Dialysis and immunosuppressants therapy were associated with greater risk of HZ disease in CKD patients. Further guideline may highlight the necessity of zoster vaccine for patients with CKD, who undertake associated treatment.<\/jats:p>","DOI":"10.3390\/vaccines9090963","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:58:15Z","timestamp":1630450695000},"page":"963","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk Factors for Herpes Zoster in Patients with Chronic Kidney Disease: A Case-Control Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Zhenxing","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Third Xiangya Hospital of Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China"},{"name":"Hunan Key Laboratory of Brain Homeostasis, Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Third Xiangya Hospital of Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-2005","authenticated-orcid":false,"given":"Haocheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pain, Institute of Pain Medicine, Third Xiangya Hospital of Central South University, Changsha 410013, China"},{"name":"Hunan Key Laboratory of Brain Homeostasis, Central South University, Changsha 410013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and Prevention (2019). Chronic Kidney Disease in the United States, US Department of Health and Human Services, Centers for Disease Control and Prevention."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: A systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ndt\/16.6.1120","article-title":"Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries","volume":"16","author":"Jager","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"(2016, April 27). Overall Immune Profile and Effect of Chronic Kidney Disease on Vaccination Schedule. Available online: https:\/\/www.indianjnephrol.org\/text.asp?2016\/26\/7\/2\/181294.","DOI":"10.4103\/0971-4065.181294"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"g2911","DOI":"10.1136\/bmj.g2911","article-title":"Quantification of risk factors for herpes zoster: Population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2012.03.018","article-title":"Risk of herpes zoster in CKD: A matched-cohort study based on administrative data","volume":"60","author":"Wu","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ajkd.2011.10.049","article-title":"Risk of herpes zoster in patients treated with long-term hemodialysis: A matched cohort study","volume":"59","author":"Kuo","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_11","first-page":"263","article-title":"End-stage renal disease (ESRD) contributes to the increasing prevalence of herpes zoster","volume":"2","author":"Sato","year":"2009","journal-title":"NDT Plus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-3062.2007.00289.x","article-title":"Varicella zoster virus-associated disease in adult kidney transplant recipients: Incidence and risk-factor analysis","volume":"10","author":"Arness","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.0000000000002808","article-title":"Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study","volume":"87","author":"Forbes","year":"2016","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.36076\/ppj.2017.E220","article-title":"Prevention of Post-herpetic Neuralgia from Dream to Reality: A Ten-step Model","volume":"20","author":"Makharita","year":"2017","journal-title":"Pain Physician"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","article-title":"Increased risk of stroke after a herpes zoster attack: A population-based follow-up study","volume":"40","author":"Kang","year":"2009","journal-title":"Stroke"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.07.013","article-title":"Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality","volume":"90","author":"Tang","year":"2016","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s10096-014-2143-6","article-title":"Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: A population-based cohort study","volume":"33","author":"Lin","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med. J."},{"key":"ref_19","first-page":"462","article-title":"Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease","volume":"62","author":"Tseng","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Nogu\u00e9, M., Rambaud, J., Fabre, S., Filippi, N., Jorgensen, C., and Pers, Y.M. (2019). Long-term corticosteroid use and dietary advice: A qualitative analysis of the difficulties encountered by patient. BMC Health Serv. Res., 19.","DOI":"10.1186\/s12913-019-4052-y"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semnephrol.2009.06.006","article-title":"Interaction of aging and chronic kidney disease","volume":"29","author":"Prakash","year":"2009","journal-title":"Semin. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","article-title":"Herpes Zoster in the Older Adult","volume":"31","author":"John","year":"2017","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ckj\/sfy058","article-title":"Mortality risk after herpes zoster infection in end-stage renal disease patients","volume":"12","author":"Ahn","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e014032","DOI":"10.1136\/bmjopen-2016-014032","article-title":"Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: A case-control study in Asia","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2015.12.059","article-title":"Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study","volume":"75","author":"Hu","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ekir.2019.08.019","article-title":"Steroid-Associated Side Effects in Patients with Primary Proteinuric Kidney Disease","volume":"4","author":"Oh","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000339004","article-title":"A comparison of herpes zoster incidence across the spectrum of chronic kidney disease, dialysis and transplantation","volume":"36","author":"Lin","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000328730","article-title":"Varicella zoster infection in renal transplant recipients: Prevalence, complications and outcome","volume":"34","author":"Mustapic","year":"2011","journal-title":"Kidney Blood Press. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: Basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2215\/CJN.01290308","article-title":"Epidemiology of acute infections among patients with chronic kidney disease","volume":"3","author":"Dalrymple","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/s41598-020-59794-7","article-title":"Infection in Advanced Chronic Kidney Disease and Subsequent Adverse Outcomes after Dialysis Initiation: A Nationwide Cohort Study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1681\/ASN.2004110910","article-title":"General medical care among patients with chronic kidney disease: Opportunities for improving outcomes","volume":"16","author":"Kausz","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/ndt\/gfg190","article-title":"Laboratory assessment of immune function in renal transplant patients","volume":"18","author":"Hutchinson","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lamarche, C., Iliuta, I.A., and Kitzler, T. (2019). Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach. Can. J. Kidney Health Dis., 29.","DOI":"10.1177\/2054358119839080"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2009020213","article-title":"Reassessment of albumin as a nutritional marker in kidney disease","volume":"21","author":"Friedman","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41100-018-0173-8","article-title":"Low serum albumin as a risk factor for infection-related in-hospital death among hemodialysis patients hospitalized on suspicion of infectious disease: A Japanese multicenter retrospective cohort study","volume":"4","author":"Minatoguchi","year":"2018","journal-title":"Ren. Replace Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/infdis\/jiy383","article-title":"Comparative Immune Responses to Licensed Herpes Zoster Vaccines","volume":"218","author":"Weinberg","year":"2018","journal-title":"J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/9\/963\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:30Z","timestamp":1760165670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/9\/963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["vaccines9090963"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9090963","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]}}}